Finance

Lists
Q3 2026 earnings • in 2 days
See details
HSTM:NASDAQ
HealthStream Inc
$35.16
+1.65%
(+0.57) 1D
Oct 23, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for HSTM...
Open
$34.39
High
$35.23
Low
$34.26
Mkt. cap
1.03B
Avg. vol.
189.55K
Volume
205.97K
Dividend
0.40%
Quarterly dividend
$0.03
Ex-dividend date
Aug 17, 2026
P/E ratio
48.99
52-wk high
$35.23
52-wk low
$19.50
EPS
$0.72
Beta
0.42
Shares outstanding
30.60M
No. of employees
1K
Open
$34.39
High
$35.23
Low
$34.26
Mkt. cap
1.03B
Avg. vol.
189.55K
Volume
205.97K
Dividend
0.40%
Quarterly dividend
$0.03
Ex-dividend date
Aug 17, 2026
P/E ratio
48.99
52-wk high
$35.23
52-wk low
$19.50
EPS
$0.72
Beta
0.42
Shares outstanding
30.60M
No. of employees
1K
News stories
From web sources and news partners
About HealthStream Inc
CEORobert A. Frist Jr.
Employees1.15K
Founded1990
HeadquartersNashville, Tennessee, United States
SectorHealth care
Websitehealthstream.com
Analyst ratings
Based on 4 analysts giving stock ratings to HSTM in the past 3 months
Hold
Buy
1
Hold
3
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for HSTM in the last 3 months.
Highest
Current $35.16
$36.00 (+2.39%)
Average
$32.50 (-7.57%)
Lowest
$29.00 (-17.52%)
Analyst
Recommendation
Action
Price target
Projected
Date
Eugene Mannheimer
Freedom Capital Markets
Hold
Initiated
$36.00
+2.4%
10/13/2026
Vincent Colicchio
Barrington
Hold
Maintained
-
-
10/01/2026
Richard Close
Canaccord Genuity
Hold
Maintained
$29.00
-17.5%
09/16/2026
Ryan Daniels
William Blair
Buy
Maintained
-
-
08/03/2026
Matt Hewitt
Craig-Hallum
Buy
Reiterated
$40.00
+13.8%
05/06/2026
Next call in 2 days
Mon, Oct 26, 10:00 PM
Fiscal period
Q3 2026
- / $0.14
Revenue / Est. (USD)
- / 82.16M
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
76.47M
79.71M
81.20M
83.73M
Cost of goods sold
26.51M
28.85M
27.76M
29.02M
Cost of revenue
26.51M
28.85M
27.76M
29.02M
Research and development expenses
12.11M
14.76M
13.61M
13.58M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
19.47M
22.16M
20.96M
21.54M
Operating expense
42.40M
47.95M
45.93M
46.40M
Total operating expenses
68.91M
76.80M
73.69M
75.41M
Operating income
7.57M
2.90M
7.51M
8.32M
Other non operating income
-77.00K
-2.00K
-81.00K
-75.00K
EBT including unusual items
8.25M
2.85M
7.82M
8.70M
EBT excluding unusual items
8.25M
3.35M
7.82M
8.70M
Income tax expense
2.17M
317.00K
1.91M
2.03M
Effective tax rate
26.25%
11.12%
24.42%
23.31%
Other operating expenses
-
-
-
-
Net income
6.09M
2.53M
5.91M
6.67M
Net profit margin
7.96%
3.18%
7.28%
7.96%
Earnings per share
0.20
0.18
0.20
0.23
Interest and investment income
788.00K
664.00K
414.00K
475.00K
Interest expense
-26.00K
-25.00K
-25.00K
-25.00K
Net interest expenses
762.00K
639.00K
389.00K
450.00K
Depreciation and amortization charges
10.82M
11.04M
11.36M
11.28M
EBITDA
18.39M
13.94M
18.88M
19.60M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps